Founded in 2017 by two respiratory clinicians following 11 years of NHS-led and funded research. NEPeSMO offers unique digital bio-clinical remote monitoring solutions for prediction and prevention of lung attacks and monitoring of respiratory disease. NEPeSMO has developed proprietary prediction algorithms constructed from time-series data on metrics such as, symptoms, lung function and biomarkers in blood/saliva. NEPeSMO's digital solutions are designed to be seamless and can connect wirelessly to monitoring devices. Our digital products consist of Application/Web-based software; are co-designed with patients and are bespoke to our target market. Alongside the company's digital portfolio, NEPeSMO sees saliva based biomaker analysis as the future. The company has developed expertise and has an active research and development arm in saliva based collection devices and point-of-care testing.